Centogene (NASDAQ:CNTG – Get Free Report) traded down 43% during trading on Wednesday . The company traded as low as $0.20 and last traded at $0.20. 1,255 shares were traded during trading, a decline of 99% from the average session volume of 150,868 shares. The stock had previously closed at $0.35.
Centogene Stock Performance
The firm’s fifty day moving average price is $0.21 and its two-hundred day moving average price is $0.38.
Centogene Company Profile
Centogene N.V., together with its subsidiaries, provides pharmaceutical solutions and diagnostic tests in Europe, the Middle East, North America, Latin America, and the Asia Pacific. The company offers data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases.
See Also
- Five stocks we like better than Centogene
- How to Invest in the Best Canadian Stocks
- S&P 500 Hitting Resistance: These 3 Stocks Offer the Best Upside
- Learn Technical Analysis Skills to Master the Stock Market
- Nike’s Post-Earnings Drop Presents a Buying Opportunity
- Want to Profit on the Downtrend? Downtrends, Explained.
- Microsoft’s Targeted Upside Might Be Too Good to Ignore
Receive News & Ratings for Centogene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centogene and related companies with MarketBeat.com's FREE daily email newsletter.
